<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00130429</url>
  </required_header>
  <id_info>
    <org_study_id>P58/09ME/03/04</org_study_id>
    <nct_id>NCT00130429</nct_id>
  </id_info>
  <brief_title>Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease</brief_title>
  <official_title>Phase II Randomised, Double Blind, Placebo Controlled, Parallel Group Study to Investigate the Safety, Effect on Cognition and Pharmacokinetic Profile of PYM50028 in Subjects With Mild Dementia of the Alzheimer's Type</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phytopharm</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phytopharm</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of PYM50028 administered once daily for up
      to 12 weeks on the memory and other faculties of subjects with dementia due to Alzheimer's
      disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">September 2005</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hopkins verbal learning test (revised) total word recall after 12 weeks</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Cambridge neuropsychological test automated battery (CANTAB) paired associate learning (Phytopharm modified form) total adjusted error score after 12 weeks</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mini mental state examination score</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical dementia rating (overall and sum of boxes)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CANTAB rapid visual information processing (RVIP) mean latency</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CANTAB RVIP total correct hits</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CANTAB spatial working memory within error, between error and strategy scores</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinicians global impression of change</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disability assessment for dementia score</measure>
  </secondary_outcome>
  <enrollment>250</enrollment>
  <condition>Alzheimer's Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PYM50028</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 50 years of age

          -  Diagnosis of possible or probable Alzheimer's disease

          -  Mini mental state examination score at least 16

          -  Good understanding of both written and verbal English

          -  A recent head scan that is consistent with the diagnosis of Alzheimer's disease

        Exclusion Criteria:

          -  Recent history or clinical evidence of significant neurological disease other than
             dementia due to Alzheimer's disease

          -  Known to have another condition that is associated with dementia

          -  Use of psychotropic medication within the previous 4 weeks (excluding cholinesterase
             inhibitors, selective serotonin reuptake inhibitors and venlafaxine)

          -  Hormone replacement therapy started or changed within the previous 6 months

          -  Received any investigational drugs within the previous 12 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robin Jacoby, FRCPsych</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford, UK</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oxford Project to Investigate Memory and Ageing</name>
      <address>
        <city>Oxford</city>
        <state>Oxfordshire</state>
        <zip>OX3 7JX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2005</study_first_submitted>
  <study_first_submitted_qc>August 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 15, 2005</study_first_posted>
  <last_update_submitted>August 20, 2009</last_update_submitted>
  <last_update_submitted_qc>August 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2009</last_update_posted>
  <keyword>dementia</keyword>
  <keyword>memory</keyword>
  <keyword>Hopkins verbal learning test</keyword>
  <keyword>paired associated learning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

